We are live on ! Find out more
MGNX icon

MacroGenics

124 hedge funds and large institutions have $188M invested in MacroGenics in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 46 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more call options, than puts

Call options by funds: $1.16M | Put options by funds: $835K

8.25% less ownership

Funds ownership: 97.14%88.89% (-8.3%)

15% less funds holding

Funds holding: 146124 (-22)

15% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 46

27% less capital invested

Capital invested by funds: $259M → $188M (-$70.7M)

60% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 35

Holders
124
Holders Change
-22
Holders Change %
-15.07%
% of All Funds
1.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
39
Reduced
46
Closed
35
Calls
$1.16M
Puts
$835K
Net Calls
+$322K
Net Calls Change
+$1.15M
Name Holding Trade Value Shares
Change
Change in
Stake
BG
1
Bellevue Group
Switzerland
$32.7M -$48.1K -12,350 -0.1%
AC
2
Armistice Capital
New York
$20.6M +$1.01M +258,000 +4%
BlackRock
3
BlackRock
New York
$17.8M +$14.6K +3,744 +0.1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$14.3M +$866K +222,221 +5%
Millennium Management
5
Millennium Management
New York
$11.6M +$870K +223,228 +7%
FLSM
6
Frazier Life Sciences Management
California
$9.91M
WA
7
Wasatch Advisors
Utah
$8.34M +$327K +84,005 +3%
PA
8
Pinnacle Associates
New York
$6.62M +$197K +50,661 +8%
State Street
9
State Street
Massachusetts
$4.7M -$449K -115,200 -7%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$4.63M -$32.6K -8,363 -0.6%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$4.13M -$323K -82,784 -6%
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$3.59M +$1.97M +505,746 +86%
RSCM
13
Rock Springs Capital Management
Maryland
$3.47M
Two Sigma Advisers
14
Two Sigma Advisers
New York
$3.43M -$418K -107,396 -9%
Two Sigma Investments
15
Two Sigma Investments
New York
$2.91M -$1.33M -340,624 -28%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$2.9M -$61.7K -15,837 -2%
VPC
17
Vestal Point Capital
New York
$2.73M +$117K +30,000 +4%
Northern Trust
18
Northern Trust
Illinois
$2.31M -$36.4K -9,348 -1%
Connor, Clark & Lunn Investment Management (CC&L)
19
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.18M +$728K +186,858 +39%
Jacobs Levy Equity Management
20
Jacobs Levy Equity Management
New Jersey
$1.86M +$574K +147,438 +35%
Jane Street
21
Jane Street
New York
$1.72M +$136K +34,996 +7%
Charles Schwab
22
Charles Schwab
California
$1.62M -$69.1K -17,740 -3%
AQR Capital Management
23
AQR Capital Management
Connecticut
$1.39M +$1.09M +280,455 +196%
Macquarie Group
24
Macquarie Group
Australia
$1.38M
Marshall Wace
25
Marshall Wace
United Kingdom
$1.26M -$1.08M -276,491 -42%

MGNX Hedge Fund Activity: Q3 2024 in Review

124 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2024, worth a combined $188M — down 27% from $259M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of MGNX and 14 opened new positions — a net loss of 21 holders — while 46 trimmed existing stakes and 39 added.

The largest buyer was Acadian Asset Management, adding an estimated $1.97M. The largest seller was RA Capital Management, exiting entirely with an estimated $8.85M sold.

  • 124 institutional investors held MacroGenics (MGNX) as of Q3 2024, down from 146 in Q2 2024.
  • Funds reported $188M of MacroGenics stock for Q3 2024, down 27% quarter-over-quarter.
  • 14 funds opened new MacroGenics positions in Q3 2024 and 35 closed out, a net change of -21 holders.
  • The largest MacroGenics buyer in Q3 2024 was Acadian Asset Management, an estimated $1.97M added.
  • The largest MacroGenics seller in Q3 2024 was RA Capital Management, an estimated $8.85M sold.

Based on aggregated 13F filings for Q3 2024.